A delayed-release oral wafer designed to deliver mesalazine directly to the colon, reducing inflammation in ulcerative colitis while minimizing systemic absorption.Indications:- Management of mild to moderate ulcerative colitis flares.- Maintenance therapy to help prevent relapse in ulcerative colitis.- Treatment of crohn's disease.Main Active Ingredient:- Mesalazine (each tablet 400 mg).Precautions:- Not for use in case of known sulfa or mesalazine allergy.- Caution in patients with kidney or liver disease, and those with blood disorders.- Regular monitoring of blood counts, renal and hepatic function advisable.- Notify your doctor if pregnant, planning pregnancy, or breastfeeding.- Store in original packaging at room temperature, away from moisture and children.Side Effects:- Most commonly: nausea, headache, abdominal discomfort.- Possible local irritation or mild allergic reactions.Drug–Drug Interactions:- Warfarin and other anticoagulants.- NSAIDs.- Azathioprine or 6-mercaptopurine.

- Generally take 1 tablet (400 mg) three times daily during or after meals, or as directed by your physician.- Swallow whole with water, do not crush or chew.- Continue full treatment course even if symptoms improve.- If you miss a dose, take as soon as you remember unless it's nearly time for the next dose; avoid doubling.

• Digestive health
• Anti-spasmodic
• Colic relief

Mesalazine (active ingredient), lactose monohydrate, sodium starch glycolate (Type A), magnesium stearate, purified talc, povidone, methacrylic acid-methyl methacrylate copolymer (film-coating), triethyl citrate, iron oxide yellow, iron oxide red, macrogol 600